HRMY Harmony Biosciences Holdings, Inc.

$33.30 -1.32%

Healthcare · Pharmaceutical Preparations

Harmony Biosciences Holdings, Inc. (HRMY) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $1.9 billion. Shares last traded at $33.30, 18.5% below their 52-week high. Over the past year the stock is up 2.6%. HRMY trades at a price-to-earnings ratio of 12.15, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 18.3%, above the peer median of -0.1%. Revenue grew 21.5% year over year.

Market Cap

$1.9B

Shares Out

57.9M

EPS (TTM)

$5.11

P/E Ratio

6.52

P/S Ratio

2.22

P/B Ratio

2.12

Dividend / Share

—

Dividend Yield

—

52-Week High

$40.87

52-Week Low

$25.52

Volume

20,676

Avg Vol (3m)

50,656.111

Performance

-5.44%

+9.38%

+19.85%

-14.29%

YTD

-10.91%

+2.57%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

55.01

SMA (50)

$31.47

SMA (200)

$32.29

Price vs SMA50

+5.85%

Price vs SMA200

+3.15%

ATR (14)

$1.68

Financials

Revenue

$868M

Net Income

$159M

Gross Margin

77.2%

Operating Margin

24.0%

Net Margin

18.3%

Return on Equity

17.4%

Return on Assets

12.5%

Current Ratio

3.58

Debt / Equity

0.17

Revenue Growth (YoY)

+21.5%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.55	2026-05-07
FY 2025	$2.71	2026-02-24
Q3 2025	$2.32	2025-11-04
Q2 2025	$1.46	2025-08-05
Q1 2026	$0.78	2026-05-07
FY 2025	$2.51	2026-02-24

Full earnings history →

Pharmaceutical Preparations peers

HRMY vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

12.15 / 16.82 med

-28% discount

P/S vs peers

2.22 / 3.54 med

-37% discount

Net margin vs peers

18.3% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.